Mature B-Cell Lymphoma And Leukemia Study III

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This is a phase III clinical trial using risk-adapted therapy. Treatment outcomes for children with B-cell NHL are excellent. Further improvements in outcome will likely be achieved through more focused study of the biology of the tumors and prospective studies of the late effects of treatment. Toward this end, this study features a spectrum of prospective biologic and late effect studies performed in patients treated with a modified regimen derived from the very successful LMB-96 regimen.
Epistemonikos ID: 52bccf195a2c6269b705461bbab4b31990b4eded
First added on: May 05, 2024